172 related articles for article (PubMed ID: 20862567)
1. EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model.
Ke X; Yang YC; Hong SL
Med Oncol; 2011 Dec; 28 Suppl 1():S326-32. PubMed ID: 20862567
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence visualization screening for EBV-LMP1-targeted DNAzymes.
You X; Yang YC; Ke X; Hong SL; Hu GH
Otolaryngol Head Neck Surg; 2014 Feb; 150(2):251-8. PubMed ID: 24323909
[TBL] [Abstract][Full Text] [Related]
3. DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas.
Liao WH; Yang LF; Liu XY; Zhou GF; Jiang WZ; Hou BL; Sun LQ; Cao Y; Wang XY
BMC Cancer; 2014 Nov; 14():835. PubMed ID: 25407966
[TBL] [Abstract][Full Text] [Related]
4. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma.
Lu ZX; Ma XQ; Yang LF; Wang ZL; Zeng L; Li ZJ; Li XN; Tang M; Yi W; Gong JP; Sun LQ; Cao Y
Cancer Lett; 2008 Jul; 265(2):226-38. PubMed ID: 18353539
[TBL] [Abstract][Full Text] [Related]
5. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas.
Cao Y; Yang L; Jiang W; Wang X; Liao W; Tan G; Liao Y; Qiu Y; Feng D; Tang F; Hou BL; Zhang L; Fu J; He F; Liu X; Jiang W; Yang T; Sun LQ
Mol Ther; 2014 Feb; 22(2):371-377. PubMed ID: 24322331
[TBL] [Abstract][Full Text] [Related]
7. EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma.
Yang L; Liu L; Xu Z; Liao W; Feng D; Dong X; Xu S; Xiao L; Lu J; Luo X; Tang M; Bode AM; Dong Z; Sun L; Cao Y
Oncotarget; 2015 Mar; 6(8):5804-17. PubMed ID: 25714020
[TBL] [Abstract][Full Text] [Related]
8. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
Chang PY; Wu ZZ; Sun NK; Chao CC
J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
[TBL] [Abstract][Full Text] [Related]
9. Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.
Yang L; Xu Z; Liu L; Luo X; Lu J; Sun L; Cao Y
Cancer Biol Ther; 2014 Jan; 15(1):61-8. PubMed ID: 24145206
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-κB regulated ATM expression.
Ma X; Yang L; Xiao L; Tang M; Liu L; Li Z; Deng M; Sun L; Cao Y
PLoS One; 2011; 6(11):e24647. PubMed ID: 22096476
[TBL] [Abstract][Full Text] [Related]
11. A human Fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo.
Chen R; Zhang D; Mao Y; Zhu J; Ming H; Wen J; Ma J; Cao Q; Lin H; Tang Q; Liang J; Feng Z
Mol Cancer Ther; 2012 Mar; 11(3):594-603. PubMed ID: 22169768
[TBL] [Abstract][Full Text] [Related]
12. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
13. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis.
Lu ZX; Ye M; Yan GR; Li Q; Tang M; Lee LM; Sun LQ; Cao Y
Cancer Gene Ther; 2005 Jul; 12(7):647-54. PubMed ID: 15803142
[TBL] [Abstract][Full Text] [Related]
14. A therapeutic approach to nasopharyngeal carcinomas by DNAzymes targeting EBV LMP-1 gene.
Yang L; Lu Z; Ma X; Cao Y; Sun LQ
Molecules; 2010 Sep; 15(9):6127-39. PubMed ID: 20877211
[TBL] [Abstract][Full Text] [Related]
15. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
[TBL] [Abstract][Full Text] [Related]
16. Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.
Wasil LR; Wei L; Chang C; Lan L; Shair KH
J Virol; 2015 Aug; 89(15):7612-24. PubMed ID: 25972552
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
18. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
[TBL] [Abstract][Full Text] [Related]
19. Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.
Lo AK; Dawson CW; Young LS; Ko CW; Hau PM; Lo KW
J Pathol; 2015 Oct; 237(2):238-48. PubMed ID: 26096068
[TBL] [Abstract][Full Text] [Related]
20. FosPeg® PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells.
Wu RW; Chu ES; Huang Z; Xu CS; Ip CW; Yow CM
J Photochem Photobiol B; 2013 Oct; 127():114-22. PubMed ID: 24013466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
